| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |